Evaluating Strategies to Improve Patient Outcomes: Community-Acquired and Nosocomial MRSA CME
Faculty: Kamal M.F. Itani, MD, FACS; Lena M. Napolitano, MD, FACS, FCCP, FCCM; Dennis L. Stevens, MD, PhD; CME Reviewer: Andrew W. Urban, MD
Disclosures

Release Date: February 27, 2006; Valid for credit through February 27, 2007


This CME activity is based on transcripts and slides of presentations as delivered by the faculty at the "Evaluating Strategies to Improve Patient Outcomes: Community-Acquired and Nosocomial MRSA" symposium held at the San Francisco Marriott in San Francisco, CA on October 18, 2005.

Contents of This CME Activity
This activity is offered in two formats. Please choose one of the versions:

    Slides and Audio Version
    (A multimedia presentation with synchronized audio, slides and transcript.)
    Note: Macromedia's Flash Player 5 plug-in is required to view the Flash version.
    Download the Macromedia Flash Player 5 plug-In:

    Get Flash 5

    --OR--

    Slides with transcript:

  1. The Independent Evolution of Healthcare-Associated and Community-Acquired MRSA
    by Dennis L. Stevens, MD, PhD
    Hospital-Acquired MRSA
    Community-Acquired MRSA
    Distinguishing Hospital-Acquired MRSA From Community-Acquired MRSA
    Using Staphylococcal Cassette and Toxin Genes to Classify Organisms
    Antimicrobial Susceptibility of MRSA

  2. Surgical Site and Complicated Skin and Skin Structure Infections: Epidemiology, Prevention, and Emerging Treatment Guidelines
    by Lena M. Napolitano, MD, FACS, FCCP, FCCM
    Surgical Site Infection: Epidemiology
    Surgical Site Infection: Classification, Risk Factors, Wound Classification
    Campaign to Prevent Antimicrobial Resistance
    Prevention of Surgical Site Infection
    Prevention of Surgical Site Infection: Antimicrobial Prophylaxis
    Surgical Care Improvement Project: A National Quality Partnership
    Surgical Infection Prevention: National Data Collection
    Surgical Site Infection Challenges: Resistant Pathogens
    Impact of MRSA
    Impact of MRSA (cont'd)
    MRSA: Recent Guidelines
    Surgical Site Infection and Mupirocin
    Preventive Strategies for Surgical Site Infection
    Skin and Soft Tissue Infection
    MRSA in Skin and Soft Tissue Infection
    Treatment of Infection

  3. Emerging Data, Emerging Agents: Treatment of Complicated Skin and Skin Structure Infection
    by Kamal M.F. Itani, MD, FACS
    Skin and Soft Tissue Infection
    Microbiology of Skin and Soft Tissue Infection
    Community-Acquired and Hospital-Acquired MRSA
    Treatment Approaches
    Vancomycin
    Comparison of MRSA Antimicrobials
    Quinupristin/Dalfopristin
    Linezolid
    Daptomycin
    Other Agents for Treatment of Skin and Soft Tissue Infections

  4. Maximizing Efficacy: Differences in Managing Community-Acquired and Nosocomial MRSA
    by Dennis L. Stevens, MD, PhD
    Managing MRSA Infections
    Antibiotics for MRSA Infections
    Vancomycin Treatment of MRSA
    Other Issues With Vancomycin
    Toxins in MRSA
    Case Study
    Case Study (cont'd)
    Summary

Take this program with you!
Download this Web Conference as an MP3 and load it onto your iPod or other portable audio player for audio CME on-the-go.
audio MP3 Audio file Dennis L. Stevens, MD, PhD
MP3 Audio file Lena M. Napolitano, MD, FACS, FCCP, FCCM
MP3 Audio file Kamal M.F. Itani, MD, FACS
MP3 Audio file Dennis L. Stevens, MD, PhD
(Right-click and select "Save Target As…" to download)
These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

 
Copyright © 2006 University of Wisconsin School of Medicine and Public Health.
Pfizer
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
 
The University of Wisconsin School of Medicine and Public Health
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Wisconsin School of Medicine and Public Health and Rxperience. The University of Wisconsin School of Medicine and Public Health is accredited by the ACCME to provide continuing medical education for physicians.

The University of Wisconsin School of Medicine and Public Health designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.